Clinical Trial Update: Omega 3 Supplementation in Cystic Fibrosis Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating omega-3 fatty acid supplementation in patients with cystic fibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Omega-3 fatty acids supplement (Omega-3 fatty acids)

Snippet

Sponsor: Queen Fabiola Children's University Hospital | Conditions: Cystic Fibrosis | Phase 3 | Status: COMPLETED